价格

BY-13

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES
EP 4276108 A3申请人: ABBVIE INC优先权: 2016
CN
EP
US
7 件公开
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
US 9572863 B2申请人: PIERIS PHARMACEUTICALS GMBH优先权: 2012
US
6 件公开
COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
US 2022388991 A1申请人: IDEMITSU KOSAN CO优先权: 2019
CN
US
WO
4 件公开
Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)
US 7785590 B2申请人: ZENYTH OPERATIONS PTY LTD优先权: 2002
US
4 件公开
ASTHMA TREATMENT BY BLOCKING IL-13 AND TSLP
- EP 4688839 A1
  申请人: SANOFI SA优先权: 2023
  CN
  EP
  WO
  3 件公开
- EP 4435004 A1
  申请人: SANOFI SA优先权: 2023
  EP
  2 件公开
Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
EP 2123674 A1申请人: GENETICS INST LLC优先权: 2000
EP
US
3 件公开
MRI CONTRAST MEDIUM INCLUDING CARBON-13-CONTAINING GRAPHENE QUANTUM DOT AND PREPARATION METHOD THEREFOR
US 2023302161 A1申请人: BIOGRAPHENE INC优先权: 2020
CN
US
2 件公开
Secreted proteins encoded by human chromosome 13
US 2005287584 A1申请人: ZYMOGENETICS INC优先权: 2001
US
2 件公开
Type 2 cytokine receptor and nucleic acids encoding same
US 2009232809 A1申请人: WYETH CORP优先权: 2002
US
2 件公开
Method for producing quaterrylene-3,4:13, 14-tetracarboxy diimides by direct synthesis
US 7741487 B2申请人: BASF AG优先权: 2004
US
2 件公开

药物

BY-13

专利

ASTHMA TREATMENT BY BLOCKING IL-13 AND TSLP